Report Detail
Global Fluoxetine Market Professional Survey Report 2019
- RnM3765990 |
- 20 September, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Chemical & Material
Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
The global Fluoxetine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fluoxetine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fluoxetine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fluoxetine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fluoxetine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablets
Capsules
Oral Solution
Segment by Application
Depression
Obsessive–compulsive disorder
Panic disorder
Bulimia nervosa
Others
Table of Contents
Executive Summary
1 Industry Overview of Fluoxetine
- 1.1 Definition of Fluoxetine
- 1.2 Fluoxetine Segment by Type
- 1.2.1 Global Fluoxetine Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Tablets
- 1.2.3 Capsules
- 1.2.4 Oral Solution
- 1.3 Fluoxetine Segment by Applications
- 1.3.1 Global Fluoxetine Consumption Comparison by Applications (2014-2025)
- 1.3.2 Depression
- 1.3.3 Obsessive–compulsive disorder
- 1.3.4 Panic disorder
- 1.3.5 Bulimia nervosa
- 1.3.6 Others
- 1.4 Global Fluoxetine Overall Market
- 1.4.1 Global Fluoxetine Revenue (2014-2025)
- 1.4.2 Global Fluoxetine Production (2014-2025)
- 1.4.3 North America Fluoxetine Status and Prospect (2014-2025)
- 1.4.4 Europe Fluoxetine Status and Prospect (2014-2025)
- 1.4.5 China Fluoxetine Status and Prospect (2014-2025)
- 1.4.6 Japan Fluoxetine Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Fluoxetine Status and Prospect (2014-2025)
- 1.4.8 India Fluoxetine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Fluoxetine
- 2.3 Manufacturing Process Analysis of Fluoxetine
- 2.4 Industry Chain Structure of Fluoxetine
3 Development and Manufacturing Plants Analysis of Fluoxetine
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Fluoxetine Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Fluoxetine
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Fluoxetine Production and Capacity Analysis
- 4.2 Fluoxetine Revenue Analysis
- 4.3 Fluoxetine Price Analysis
- 4.4 Market Concentration Degree
5 Fluoxetine Regional Market Analysis
- 5.1 Fluoxetine Production by Regions
- 5.1.1 Global Fluoxetine Production by Regions
- 5.1.2 Global Fluoxetine Revenue by Regions
- 5.2 Fluoxetine Consumption by Regions
- 5.3 North America Fluoxetine Market Analysis
- 5.3.1 North America Fluoxetine Production
- 5.3.2 North America Fluoxetine Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Fluoxetine Import and Export
- 5.4 Europe Fluoxetine Market Analysis
- 5.4.1 Europe Fluoxetine Production
- 5.4.2 Europe Fluoxetine Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Fluoxetine Import and Export
- 5.5 China Fluoxetine Market Analysis
- 5.5.1 China Fluoxetine Production
- 5.5.2 China Fluoxetine Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Fluoxetine Import and Export
- 5.6 Japan Fluoxetine Market Analysis
- 5.6.1 Japan Fluoxetine Production
- 5.6.2 Japan Fluoxetine Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Fluoxetine Import and Export
- 5.7 Southeast Asia Fluoxetine Market Analysis
- 5.7.1 Southeast Asia Fluoxetine Production
- 5.7.2 Southeast Asia Fluoxetine Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Fluoxetine Import and Export
- 5.8 India Fluoxetine Market Analysis
- 5.8.1 India Fluoxetine Production
- 5.8.2 India Fluoxetine Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Fluoxetine Import and Export
6 Fluoxetine Segment Market Analysis (by Type)
- 6.1 Global Fluoxetine Production by Type
- 6.2 Global Fluoxetine Revenue by Type
- 6.3 Fluoxetine Price by Type
7 Fluoxetine Segment Market Analysis (by Application)
- 7.1 Global Fluoxetine Consumption by Application
- 7.2 Global Fluoxetine Consumption Market Share by Application (2014-2019)
8 Fluoxetine Major Manufacturers Analysis
- 8.1 Teva
- 8.1.1 Teva Fluoxetine Production Sites and Area Served
- 8.1.2 Teva Product Introduction, Application and Specification
- 8.1.3 Teva Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Sun Pharmaceutical
- 8.2.1 Sun Pharmaceutical Fluoxetine Production Sites and Area Served
- 8.2.2 Sun Pharmaceutical Product Introduction, Application and Specification
- 8.2.3 Sun Pharmaceutical Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Sandoz
- 8.3.1 Sandoz Fluoxetine Production Sites and Area Served
- 8.3.2 Sandoz Product Introduction, Application and Specification
- 8.3.3 Sandoz Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Mylan
- 8.4.1 Mylan Fluoxetine Production Sites and Area Served
- 8.4.2 Mylan Product Introduction, Application and Specification
- 8.4.3 Mylan Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Wockhardt
- 8.5.1 Wockhardt Fluoxetine Production Sites and Area Served
- 8.5.2 Wockhardt Product Introduction, Application and Specification
- 8.5.3 Wockhardt Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Dr.Reddy's Laboratories
- 8.6.1 Dr.Reddy's Laboratories Fluoxetine Production Sites and Area Served
- 8.6.2 Dr.Reddy's Laboratories Product Introduction, Application and Specification
- 8.6.3 Dr.Reddy's Laboratories Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Pharmaceutical Associates Inc.
- 8.7.1 Pharmaceutical Associates Inc. Fluoxetine Production Sites and Area Served
- 8.7.2 Pharmaceutical Associates Inc. Product Introduction, Application and Specification
- 8.7.3 Pharmaceutical Associates Inc. Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Lannett Company
- 8.8.1 Lannett Company Fluoxetine Production Sites and Area Served
- 8.8.2 Lannett Company Product Introduction, Application and Specification
- 8.8.3 Lannett Company Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Aurobindo Pharma
- 8.9.1 Aurobindo Pharma Fluoxetine Production Sites and Area Served
- 8.9.2 Aurobindo Pharma Product Introduction, Application and Specification
- 8.9.3 Aurobindo Pharma Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Alembic Pharmaceuticals
- 8.10.1 Alembic Pharmaceuticals Fluoxetine Production Sites and Area Served
- 8.10.2 Alembic Pharmaceuticals Product Introduction, Application and Specification
- 8.10.3 Alembic Pharmaceuticals Fluoxetine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Alvogen
- 8.12 Torrent Pharmaceuticals
- 8.13 Suzhou YUSHI Pharmaceutical
- 8.14 Changzhou Siyao Pharmaceutical
9 Development Trend of Analysis of Fluoxetine Market
- 9.1 Global Fluoxetine Market Trend Analysis
- 9.1.1 Global Fluoxetine Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Fluoxetine Regional Market Trend
- 9.2.1 North America Fluoxetine Forecast 2019-2025
- 9.2.2 Europe Fluoxetine Forecast 2019-2025
- 9.2.3 China Fluoxetine Forecast 2019-2025
- 9.2.4 Japan Fluoxetine Forecast 2019-2025
- 9.2.5 Southeast Asia Fluoxetine Forecast 2019-2025
- 9.2.6 India Fluoxetine Forecast 2019-2025
- 9.3 Fluoxetine Market Trend (Product Type)
- 9.4 Fluoxetine Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Fluoxetine Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Fluoxetine. Industry analysis & Market Report on Fluoxetine is a syndicated market report, published as Global Fluoxetine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Fluoxetine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
